These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 7766075)
21. Evaluation of aerobic bacteriologic culture of epidermal collarette specimens in dogs with superficial pyoderma. White SD; Brown AE; Chapman PL; Jang SS; Ihrke PJ J Am Vet Med Assoc; 2005 Mar; 226(6):904-8. PubMed ID: 15786991 [TBL] [Abstract][Full Text] [Related]
22. Immunoglobulin G responses in 21 dogs with skin diseases to antigens from different isolates of Staphylococcus intermedius. Neuber AE; Thoday KL; Hill PB Vet Rec; 2008 Jan; 162(3):75-9. PubMed ID: 18204030 [TBL] [Abstract][Full Text] [Related]
23. Chloramphenicol resistance in Staphylococcus intermedius from a single veterinary centre: evidence for plasmid and chromosomal location of the resistance genes. Schwarz S; Werckenthin C; Pinter L; Kent LE; Noble WC Vet Microbiol; 1995 Feb; 43(2-3):151-9. PubMed ID: 7740754 [TBL] [Abstract][Full Text] [Related]
24. Antimicrobial susceptibility profiles of Staphylococcus intermedius isolates from clinical cases of canine pyoderma in South Africa. Blunt CA; van Vuuren M; Picard J J S Afr Vet Assoc; 2013 May; 84(1):E1-6. PubMed ID: 23718758 [TBL] [Abstract][Full Text] [Related]
25. Nasal carriage of Staphylococcus schleiferi from healthy dogs and dogs with otitis, pyoderma or both. May ER; Kinyon JM; Noxon JO Vet Microbiol; 2012 Dec; 160(3-4):443-8. PubMed ID: 22771206 [TBL] [Abstract][Full Text] [Related]
26. Canine superficial bacterial pyoderma: evaluation of skin surface sampling methods and antimicrobial susceptibility of causal Staphylococcus isolates. Ravens PA; Vogelnest LJ; Ewen E; Bosward KI; Norris JM Aust Vet J; 2014 May; 92(5):149-55. PubMed ID: 24766044 [TBL] [Abstract][Full Text] [Related]
27. Identification of a novel Staphylococcus pseudintermedius exfoliative toxin gene and its prevalence in isolates from canines with pyoderma and healthy dogs. Iyori K; Hisatsune J; Kawakami T; Shibata S; Murayama N; Ide K; Nagata M; Fukata T; Iwasaki T; Oshima K; Hattori M; Sugai M; Nishifuji K FEMS Microbiol Lett; 2010 Nov; 312(2):169-75. PubMed ID: 20875053 [TBL] [Abstract][Full Text] [Related]
28. Frequency and antimicrobial susceptibility of Staphylococcus species isolated from canine pyodermas. Medleau L; Long RE; Brown J; Miller WH Am J Vet Res; 1986 Feb; 47(2):229-31. PubMed ID: 3954195 [TBL] [Abstract][Full Text] [Related]
29. Antimicrobial resistance of Staphylococcus pseudintermedius isolates from healthy dogs and dogs affected with pyoderma in Japan. Onuma K; Tanabe T; Sato H Vet Dermatol; 2012 Feb; 23(1):17-22, e5. PubMed ID: 21745248 [TBL] [Abstract][Full Text] [Related]
30. Staphylococcus intermedius binding to immobilized fibrinogen, fibronectin and cytokeratin in vitro. Schmidt V; Nuttall T; Fazakerley J; McEwan N Vet Dermatol; 2009 Oct; 20(5-6):502-8. PubMed ID: 20178488 [TBL] [Abstract][Full Text] [Related]
31. Antimicrobial drug susceptibility of Staphylococcus intermedius clinical isolates from canine pyoderma. Ganiere JP; Medaille C; Mangion C J Vet Med B Infect Dis Vet Public Health; 2005 Feb; 52(1):25-31. PubMed ID: 15702997 [TBL] [Abstract][Full Text] [Related]
32. Investigation of the antibiotic resistance and biofilm formation of Staphylococcus pseudintermedius strains isolated from canine pyoderma. Stefanetti V; Bietta A; Pascucci L; Marenzoni ML; Coletti M; Franciosini MP; Passamonti F; Casagrande Proietti P Vet Ital; 2017 Dec; 53(4):289-296. PubMed ID: 29307122 [TBL] [Abstract][Full Text] [Related]
33. Tylosin in the treatment of canine superficial pyoderma. Harvey RG Vet Rec; 1996 Aug; 139(8):185-7. PubMed ID: 8873399 [TBL] [Abstract][Full Text] [Related]
34. Usefulness of cefovecin disk-diffusion test for predicting mecA gene-containing strains of Staphylococcus pseudintermedius and clinical efficacy of cefovecin in dogs with superficial pyoderma. Iyori K; Toyoda Y; Ide K; Iwasaki T; Nishifuji K Vet Dermatol; 2013 Feb; 24(1):162-7.e35-6. PubMed ID: 23331693 [TBL] [Abstract][Full Text] [Related]
35. Characterization of the canine type C enterotoxin produced by Staphylococcus intermedius pyoderma isolates. Edwards VM; Deringer JR; Callantine SD; Deobald CF; Berger PH; Kapur V; Stauffacher CV; Bohach GA Infect Immun; 1997 Jun; 65(6):2346-52. PubMed ID: 9169773 [TBL] [Abstract][Full Text] [Related]
36. Efficacy of tylosin tablets for the treatment of pyoderma due to Staphylococcus intermedius infection in dogs. Scott DW; Miller WH; Cayatte SM; Bagladi MS Can Vet J; 1994 Oct; 35(10):617-21. PubMed ID: 7994702 [TBL] [Abstract][Full Text] [Related]
37. Prevalence of meticillin-resistant Staphylococcus pseudintermedius (MRSP) from skin and carriage sites of dogs after treatment of their meticillin-resistant or meticillin-sensitive staphylococcal pyoderma. Beck KM; Waisglass SE; Dick HL; Weese JS Vet Dermatol; 2012 Aug; 23(4):369-75, e66-7. PubMed ID: 22364707 [TBL] [Abstract][Full Text] [Related]
38. Isolation of Staphylococcus schleiferi subspecies coagulans from two cases of canine pyoderma. Bes M; Guérin-Faublée V; Freney J; Etienne J Vet Rec; 2002 Apr; 150(15):487-8. PubMed ID: 11995683 [No Abstract] [Full Text] [Related]
39. Isolation of exfoliative toxin from Staphylococcus intermedius and its local toxicity in dogs. Terauchi R; Sato H; Hasegawa T; Yamaguchi T; Aizawa C; Maehara N Vet Microbiol; 2003 Jun; 94(1):19-29. PubMed ID: 12742712 [TBL] [Abstract][Full Text] [Related]
40. Multidrug- and methicillin resistant Staphylococcus pseudintermedius as a cause of canine pyoderma: a case report. Vincze S; Paasch A; Walther B; Ruscher C; Lübke-Becker A; Wieler LH; Barbara K Berl Munch Tierarztl Wochenschr; 2010; 123(9-10):353-8. PubMed ID: 21038805 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]